Closing Bell: Nervgen Pharma Corp up on Thursday (NGEN)

Today during trading, Nervgen Pharma Corp stock opened at $2.26 and closed at $2.28. Intraday prices ranged from a low of $2.22 to a high of $2.28.

Share prices gained 0.44% from the previous day's close of $2.27.

During the day across North America, the TSX Composite closed 0.30% at 21581.35, the S&P 500 closed 0.25% at 5487.03, the Dow Jones Industrial Average closed 0.15% at 38834.86 and the Nasdaq Composite closed 0.03% at 17862.23.

Nervgen Pharma Corp has listed on the Toronto Venture Exchange (TSX-V) under the ticker NGEN.

A total of 24,680 shares was traded during the session, with total trades of 38, while having an average volume of 43,332 in the last five days.

The TSX-V overall saw 2,427 price advancers against 2,794 declines and 117 unchanged.

During the prior 52 weeks, NGEN.VN has traded as high as $3.98 (February 05,2024) and low as $1.58 (December 14,2023). Moreover, in the last 12 months, Nervgen Pharma Corp's shares have gained 39.02%, while in 2024, they have shrunken -15.56%.

Following today's trading, Nervgen Pharma Corp has a market capitalization of $158.74 million on a float of 69,928 shares outstanding. Its annual EPS is $-0.34.

Nervgen Pharma Corp is a TSX Biotechnology company headquartered in Vancouver, CAN.

Currently, Nervgen Pharma Corp's consensus rating is "Strong Sell" based on 0 analysts according to Zacks. Currently, there are for the stock.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..